These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26800092)

  • 1. A protocol to develop clinical guidelines for inclusion-body myositis.
    Jones KL; Sejersen T; Amato AA; Hilton-Jones D; Schmidt J; Wallace AC; Badrising UA; Rose MR;
    Muscle Nerve; 2016 Apr; 53(4):503-7. PubMed ID: 26800092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands.
    Hoogendijk JE; Amato AA; Lecky BR; Choy EH; Lundberg IE; Rose MR; Vencovsky J; de Visser M; Hughes RA
    Neuromuscul Disord; 2004 May; 14(5):337-45. PubMed ID: 15099594
    [No Abstract]   [Full Text] [Related]  

  • 3. Current Classification and Management of Inflammatory Myopathies.
    Schmidt J
    J Neuromuscul Dis; 2018; 5(2):109-129. PubMed ID: 29865091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inclusion body myositis.
    Dimachkie MM; Barohn RJ
    Semin Neurol; 2012 Jul; 32(3):237-45. PubMed ID: 23117948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic spectrum of inclusion body myositis.
    Roy B; Dimachkie MM; Naddaf E
    Clin Exp Rheumatol; 2024 Feb; 42(2):445-453. PubMed ID: 38436356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inclusion body myositis.
    Dimachkie MM; Barohn RJ
    Neurol Clin; 2014 Aug; 32(3):629-46, vii. PubMed ID: 25037082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inclusion Body Myositis.
    Goyal NA
    Continuum (Minneap Minn); 2022 Dec; 28(6):1663-1677. PubMed ID: 36537974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inflammatory muscle diseases: dermatomyositis, polymyositis, and inclusion body myositis].
    Genth E
    Internist (Berl); 2005 Nov; 46(11):1218-32. PubMed ID: 16200404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inclusion body myositis (IBM) -- a review].
    Czaplinski A; Renaud S; Fuhr P
    Praxis (Bern 1994); 2003 Apr; 92(14):649-54. PubMed ID: 12723314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring challenges in the management and treatment of inclusion body myositis.
    Skolka MP; Naddaf E
    Curr Opin Rheumatol; 2023 Nov; 35(6):404-413. PubMed ID: 37503813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inclusion body myositis.
    Dimachkie MM; Barohn RJ
    Curr Neurol Neurosci Rep; 2013 Jan; 13(1):321. PubMed ID: 23250766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal observational study of sporadic inclusion body myositis: implications for clinical trials.
    Cortese A; Machado P; Morrow J; Dewar L; Hiscock A; Miller A; Brady S; Hilton-Jones D; Parton M; Hanna MG
    Neuromuscul Disord; 2013 May; 23(5):404-12. PubMed ID: 23489664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inclusion body myositis: MRC Centre for Neuromuscular Diseases, IBM workshop, London, 13 June 2008.
    Hilton-Jones D; Miller A; Parton M; Holton J; Sewry C; Hanna MG
    Neuromuscul Disord; 2010 Feb; 20(2):142-7. PubMed ID: 20074951
    [No Abstract]   [Full Text] [Related]  

  • 14. Myasthenia gravis with inclusion body myositis: A case report.
    Kakutani T; Yoshizawa M
    Mod Rheumatol Case Rep; 2023 Dec; 8(1):83-85. PubMed ID: 37210209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Idiopathic myositis].
    Burgunder JM
    Ther Umsch; 2003 Jul; 60(7):407-12. PubMed ID: 12956034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
    Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MODERN ASPECTS OF ETIOPATHOGENESIS, DIAGNOSIS, CLINICAL COURSE AND TREATMENT OF SPORADIC INCLUSION BODY MYOSITIS.
    Shakarishvili R; Kvirkvelia N; Nikolaishvili I; Nebadze E
    Georgian Med News; 2020 Jan; (298):80-83. PubMed ID: 32141855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inclusion Body Myositis.
    Greenberg SA
    Continuum (Minneap Minn); 2016 Dec; 22(6, Muscle and Neuromuscular Junction Disorders):1871-1888. PubMed ID: 27922498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical presentations of inclusion body myositis: Clinical characteristics and long-term outcomes.
    Alamr M; Pinto MV; Naddaf E
    Muscle Nerve; 2022 Dec; 66(6):686-693. PubMed ID: 36052422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inclusion body myositis and sarcoid myopathy: coincidental occurrence or associated diseases.
    Sanmaneechai O; Swenson A; Gerke AK; Moore SA; Shy ME
    Neuromuscul Disord; 2015 Apr; 25(4):297-300. PubMed ID: 25599912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.